JMJD2B upregulated the expression of peroxisome proliferator-activated receptor γ2 (PPARγ2) and its steatosis target genes including CD36 and fatty acid-binding protein (FABP), which are necessary for fatty acid uptake, thus resulting in the development of hepatic steatosis. Here, KDM4B is linked to fatty liver disease.